ITUS Corporation Licenses CAR-T Technology from The Wistar Institute – Markets Insider
|
ITUS Corporation Licenses CAR–T Technology from The Wistar Institute
Markets Insider SAN JOSE, Calif., Nov. 14, 2017 /PRNewswire/ — ITUS Corporation (NASDAQ: ITUS) today announced that it has executed an exclusive worldwide license agreement with The Wistar Institute for a Chimeric Antigen Receptor T–Cell (CAR-T) technology aimed … |
